(Q41046879)

26 September 2017

Cyclin D1 expression in human prostate carcinoma cell lines and primary tumors (English)

1 reference

26 September 2017

1 reference

4

1 reference

26 September 2017

Han EK

1

1 reference

26 September 2017

Lim JT

2

1 reference

26 September 2017

Arber N

3

1 reference

26 September 2017

Xing WQ

5

1 reference

26 September 2017

Weinstein IB

6

1 reference

26 September 2017

language of work or name

1 reference

1 May 1998

1 reference

26 September 2017

1 reference

26 September 2017

35

1 reference

26 September 2017

95-101

1 reference

26 September 2017

2

1 reference

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

G1 phase progression: cycling on cue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

21 January 2018

Cancer statistics, 1997.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Loss of the retinoblastoma susceptibility gene (RB1) is a frequent and early event in prostatic tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Mutational analysis of CDKN2 (CDK4I/MTS1) gene in tissues and cell lines of human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Characterization of ALVA-41 cells, a new human prostatic cancer cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Establishment and characterization of an immortalized but non-transformed human prostate epithelial cell line: BPH-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Histologic grading of prostate cancer: a perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Increased expression of cyclin D1 is an early event in multistage colorectal carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Cyclin D1 overexpression vs. retinoblastoma inactivation: implications for growth control evasion in non-small cell and small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

P16 gene in uncultured tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Tumor suppressor gene p53 mutations in human prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Mutant p53 expression in prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

p53 protein accumulation and gene mutation in the progression of human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

The PRAD-1/cyclin D1 oncogene product accumulates aberrantly in a subset of colorectal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

Rates of p16 (MTS1) mutations in primary tumors with 9p loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0045%2819980501%2935%3A2%3C95%3A%3AAID-PROS2%3E3.0.CO%3B2-F

10.1002/(SICI)1097-0045(19980501)35:2<95::AID-PROS2>3.0.CO;2-F

21 January 2018

Identifiers

DOI

1 reference

26 September 2017

1 reference